News Snapshot:
The Peril of Overlooking the Environmental Crises Behind the Farmers’ Protests A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech during a government-organised media tour in Beijing, China, September 24, 2020. Photo: REUTERS/Thomas Peter Beijing: Sinovac Biotech said on Saturday that its unit’s COVID-19 vaccine has been approved for use by the general public by China’s medical products regulator. It marks the second COVID-19 vaccine approved for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December. Both vaccines...
